Effect of methylxanthines on alloxan inhibition of insulin release
- PMID: 173610
- DOI: 10.1007/BF01222099
Effect of methylxanthines on alloxan inhibition of insulin release
Abstract
Isloated rat islets were maintained in vitro in a perifusion system, exposed to alloxan (20 mg/100 ml) for 5 minutes in the presence of agents which affect cAMP metabolism and subsequently stimulated with glucose. The rate of insulin secretion was monitored throughout the period of perifusion. Exposure to alloxan alone produces complete inhibition of glucose-induced insulin release [18] whereas concomitant exposure to carreine and theophylline for this brief interval provided almost complete protection of the islets from the inhibitory action of alloxan. Glucagon, cAMP and CBcAMP did not protect the islets form alloxan. Pre-treatment of the islets with either theophylline or glucagon and DBcAMP did not provide protection. These findings indicate that the protective action of theophylline and carreine against alloxan is unrelated to the effect of these agents on cAMP metabolism in the beta cell.
Similar articles
-
Interaction of cyclic AMP and alloxan on insulin secretion in isolated rat islets perifused in vitro.Endocrinology. 1977 May;100(5):1327-33. doi: 10.1210/endo-100-5-1327. Endocrinology. 1977. PMID: 191240
-
Effects of alloxan on glucose-stimulated insulin secretion, glucose metabolism, and cyclic adenosine 3', 5'-monophosphate levels in rat isolated islets of langerhans.Diabetologia. 1979 Feb;16(2):115-20. doi: 10.1007/BF01225460. Diabetologia. 1979. PMID: 215480
-
Alloxan stimulation and inhibition of insulin release from isolated rat islets of Langerhans.Diabetes. 1978 Dec;27(12):1205-14. doi: 10.2337/diab.27.12.1205. Diabetes. 1978. PMID: 363492
-
Alloxan: history and mechanism of action.Diabetologia. 1988 Jun;31(6):337-42. doi: 10.1007/BF02341500. Diabetologia. 1988. PMID: 3046975 Review. No abstract available.
-
Drug-induced diabetes.Baillieres Clin Endocrinol Metab. 1992 Oct;6(4):849-66. doi: 10.1016/s0950-351x(05)80170-3. Baillieres Clin Endocrinol Metab. 1992. PMID: 1445173 Review.
Cited by
-
Trypan Blue as a marker of plasma membrane permeability in alloxan-treated mouse islet cells.J Endocrinol Invest. 1979 Apr-Jun;2(2):139-45. doi: 10.1007/BF03349305. J Endocrinol Invest. 1979. PMID: 226577
-
Alloxan-induced luminol luminescence as a tool for investigating mechanisms of radical-mediated diabetogenicity.Biochem J. 1981 Dec 15;200(3):685-90. doi: 10.1042/bj2000685. Biochem J. 1981. PMID: 7342976 Free PMC article.
-
Possible toxic effects of normal and diabetic patient serum on pancreatic B-cells.Diabetologia. 1978 Jan 14;14(1):25-31. doi: 10.1007/BF00429704. Diabetologia. 1978. PMID: 342324
-
Superoxide dismutase, catalase and scavengers of hydroxyl radical protect against the toxic action of alloxan on pancreatic islet cells in vitro.Biochem J. 1979 Jul 15;182(1):17-25. doi: 10.1042/bj1820017. Biochem J. 1979. PMID: 40548 Free PMC article.
-
Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin-dependent diabetes.Mol Cell Biochem. 1981 Jun 9;37(1):43-61. doi: 10.1007/BF02355886. Mol Cell Biochem. 1981. PMID: 6166848 Review. No abstract available.